

Please try another search
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery and other vascular diseases in Europe, Latin America, the Middle East, and the Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard neuroprotection system for transcarotid access and neuro protection, as well as treating acute stroke with tandem lesions. It has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Miami, Florida.
Name | Age | Since | Title |
---|---|---|---|
Alexandre A. Abizaid | - | - | Member of Advisory Board |
Elazer R. Edelman | 68 | - | Member of Advisory Board |
Edo Kaluski | - | - | Member of Advisory Board |
Antonio Colombo | - | - | Member of Advisory Board |
Yaron Almagor | - | - | Member of Advisory Board |
Martin B. Leon | - | - | Member of Advisory Board |
Eberhart Grube | - | - | Member of Advisory Board |
Paul S. Stuka | 70 | 2011 | Independent Chairman of the Board |
Marvin L. Slosman | 61 | 2020 | President, CEO & Director |
Dariusz Dudek | - | - | Member of Advisory Board |
Bernhard Reimers | - | 2018 | Member of Advisory Board |
Gregg W. Stone | 68 | - | Member of Advisory Board |
Michael Berman | 67 | 2013 | Independent Director |
Ralf Kolvenbach | - | 2018 | Member of Advisory Board |
Adnan H. Siddiqui | - | 2022 | Member of Scientific Advisory Board & Strategic Advisor |
Thomas J. Kester | 78 | 2016 | Independent Director |
Kathryn Arnold | 50 | 2021 | Independent Director |
Piotr Musialek | - | 2018 | Member of Advisory Board |
Alberto Cremonesi | - | 2018 | Member of Advisory Board |
Gary S. Roubin | 76 | 2020 | Independent Director |
Kenneth Rosenfield | - | 2021 | Chair of Scientific Advisory Board |
Scott Raymond Ward | 65 | 2024 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review